MedPath

The influence of whole-body cryotherapy on physiological blood indicators, oxidative stress and selected disease markers in people with multiple sclerosis

Not Applicable
Completed
Conditions
Multiple Sclerosis
Physical Medicine / Rehabilitation - Physiotherapy
Neurological - Multiple sclerosis
Registration Number
ACTRN12620001142921
Lead Sponsor
Bartlomiej Ptaszek
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
45
Inclusion Criteria

• diagnosis: multiple sclerosis - ICD10: G35 (confirmed by imaging: magnetic resonance imaging, cerebrospinal fluid examination, examination of visual evoked potentials)
• age: 30 - 55 years old
• Expanded Disability Status Scale - value from 0 to 6
• no contraindications to whole body cryotherapy
• written consent of the patient to participate in the study

Exclusion Criteria

• unregulated hypertension
• atherosclerosis
• diabetes
• local blood supply disorders
• bladder and urinary tract diseases
• consuming more than 4 cups of coffee or more than 2 alcoholic beverages per day
• contraindications to the use of whole body cryotherapy
• participation in other forms of physical activity during the study
• no consent to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of changes in rheological properties of blood such as the erythrocyte elongation index (EI), erythrocyte aggregation indexes (AI), i.e. AMP - total aggregation, T1/2 - half time of total aggregation which were determined using Analizator Laser-assisted Optical Rotational Cell Analyser (LORCA) RR Mechatronics.[Baseline and after a series of 20 cryotherapy treatments];Assessment of the change in proteinogram level (total protein, albumin, alpha-1 globulin, alpha-2 globulin, beta-1 globulin, beta-2 globulin, gamma globulin, A / G index) in blood serum. The tests were carried out using the Cobas 6000, Roche analyzer (biuret method) and Minicap Sebia analyzer (capillary method).[Baseline and after a series of 20 cryotherapy treatments];Assessment of hematological parameters of the blood (Hemoglobin, g/dL; Hematocrit, %; Erythrocytes (x1012/L); Leukocyte count (x109/L); Platelet count (x109/L)) using the ABX MICROS 60 hematology analyzer (USA).[Baseline and after a series of 20 cryotherapy treatments]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath